Pantethine and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantethine (pantethine) and Abilify (aripiprazole). Common drug interactions include agitation among females.

The phase IV clinical study analyzes what interactions people have when they take Pantethine and Abilify. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Pantethine?

Pantethine has active ingredients of pantethine. eHealthMe is studying from 787 Pantethine users. Check the latest studies of Pantethine.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.

On Apr, 26, 2026

14 people who take Pantethine and Abilify together, and have interactions are studied.

Pantethine and Abilify drug interactions.

What are the common drug interactions of Pantethine and Abilify, by gender? *:

female:

Agitation (state of anxiety or nervous excitement)
Delusion (a false belief or opinion)
Hypophagia (reduced food intake)
Pancreatitis (inflammation of pancreas)
Personality change
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Somnolence (a state of near-sleep, a strong desire for sleep)
Blood creatine phosphokinase increased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

male:

n/a

What are the common drug interactions of Pantethine and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Haematotoxicity (toxins that destroy red blood cells)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Urinary tract infection
Blood creatine phosphokinase increased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Communication disorder (speech and language disorder)
Dizziness
Incontinence (lack of moderation or self-control)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)

50-59:

Hallucination (an experience involving the perception of something not present)
Hypophagia (reduced food intake)
Pancreatitis (inflammation of pancreas)
Personality change
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Somnolence (a state of near-sleep, a strong desire for sleep)
Blood creatinine increased
Blood glucose decreased
Drug eruption (adverse drug reaction of the skin)

60+:

Agitation (state of anxiety or nervous excitement)
Delusion (a false belief or opinion)
Hallucination (an experience involving the perception of something not present)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 42.86%
Insomnia (sleeplessness): 3 people, 21.43%
Type 2 Diabetes: 2 people, 14.29%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
Constipation: 2 people, 14.29%
Cytomegalovirus Infection: 2 people, 14.29%
Endometrial Cancer Recurrent: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 14.29%
Infusion Related Reaction: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Pantethine and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously